MakroCare has received AI Excellence Award this year as the Best Bio Pharma Development Partner. Acquisition International Magazine’s annual awards have been highlighting the amazing work done by those firms and individuals whose ceaseless dedication to innovation, customer care and the continued growth and improvement of their businesses has seen them forge ahead of their competitors and raise the bar for performance and results in their industry.
Here is the excerpt of the interview of Mr. Mahesh Malneedi from Acquisition International Magazine.
MakroCare’s success is a journey of over 15 years with their clients providing a broad range of knowledge-based contract research and consulting services to the worldwide pharmaceutical, biotechnology, and medical device industries. We spoke to their President and Co-founder Mahesh Malneedi about this journey, and the road that lies ahead for their company.
Since our inception, we have successfully helped clients launch products or expand into newer regions. We have Services including Regulatory Strategy for getting product approvals globally and to maintain compliance. By effectively “productizing” knowledge and experience in the form of Regulatory Affairs Center of Excellence (RACoE), MakroCare has helped clients accelerate their projects and save costs. MakroCare‘s Multidimensional Regulatory Service Accelerators (NAVA) are helping companies to pick up the pace of their Global Submissions and receive faster Approvals. In addition, our functional services include CMC Authoring, global submission management, LCM, Labeling & Affiliate support.
We are honoured to receive this prestigious Business Excellence Award. Winning award is a great morale boost for our employees, who try their best every day to deliver a full-fledged service to our Partners. And also it encourages that we are thriving the right path to help this industry’s ultimate customer, the patient.
Award is the recognition of our growth, credential and sustainability. It demonstrates the strength of the brand,increases awareness and opportunity to re-affirm our success to not only existing but potential customers too and establishes market leadership. It is the clear evidence of our employees’ passion for the business and shows their commitment to continuous improvement. So we are moving in the right direction.
Our industry is quite complex and ever changing. From drug’s efficacy, licensing impact to compliance pre & post trials, data management, analysis, regulatory acceptance, market potential; the cycle is a tough trail. To top it, the diverse regulations globally keep changing constantly. While moving ahead with newer solutions & services, we constantly connect and innovate to keep ourselves at par with clients’ need.
Our philosophy is what author Bryan Kramer has said about communication- it is neither “business to business” (B2B) nor “business to consumer” (B2C), but instead the new jargon is realised- “Human to Human”. The fact is that businesses do not have emotion. Products do not have emotion. Humans do. And in our industry we are dealing with the most fragile Human i.e. Patient. So our commitment to Clients is safe, timely and quality services & products without any excuses &compromise.
Looking towards the future, areas such as Patient Centricity and personalized medicine are taking shape as next generation focus for life sciences industry. These newer areas need a ground up innovation rather than incremental changes. This will lead to several newer opportunities to providers like MakroCare.